Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

Mutual fund · AMFI 149008

Nippon India Nifty Pharma ETF

Other Scheme: Other ETFs

NAV ₹28.95 · 17 Nov 2026

Nippon India Nifty Pharma ETF is a other etfs mutual fund run by . Its NAV was ₹28.95 on 17 Nov 2026, up 23.6% over one year and 21.7% a year over three years. The direct plan's total expense ratio was 0.23% in the latest AMFI data. The top 10 holdings made up 78.6% of the portfolio in October 2026.

Volatility (a year)14.7%
Top 10 holdings78.6% of fund
Expense ratio (direct)0.23%
Holdings20 stocks

NAV history

 

Returns from NAV

1M9.22%
6M14.96%
1Y23.58%
3Y p.a.21.71%
5Y p.a.16.19%

One year and shorter are absolute; three and five years are annualised. Based on NAV, so dividend payouts are not added back. Past performance does not guarantee future results.

Risk · last 3.0 years

How bumpy the ride has been

Volatility (a year)14.7%
Largest fall from a peak-16.6%
Sharpe ratio1.04
Sortino ratio1.6
Weeks with a fall41%

Worked out from weekly NAVs. The largest fall ran from 09 Oct 2024 to 28 Feb 2025. Sharpe and Sortino use a fixed 6.5% a year risk-free rate for comparison. Past figures are not a guide to future returns.

What the fund charges

From AMFI's expense ratio data, updated 19 Nov 2026. The regular plan charges more; see the fund's factsheet.

Total expense ratio (direct plan)0.23%
Base expense ratio0.18%
Yearly cost on ₹10 lakh₹2,300

Portfolio · October 2026

Top holdings (20 in total)

The top 10 make up 78.6% of the fund. Source: the fund house's monthly portfolio disclosure.

Since September 2026

What changed

Biggest changes in weight

  • Laurus Labs Limited7.82% to 9.26%

By sector

Where the money is

Pharmaceuticals & Biotechnology100.0%

Learn more

Mutual fund guides

Your mutual funds

Review your own mutual fund portfolio

Upload or fetch your holdings and see each fund's returns, cost and overlap against benchmarks, as facts. Review my mutual funds

Questions

About Nippon India Nifty Pharma ETF

What is the NAV of Nippon India Nifty Pharma ETF?

The net asset value was Rs 28.95 on 17 November 2026.

What is the expense ratio of Nippon India Nifty Pharma ETF?

The direct plan's total expense ratio was 0.23% in the latest AMFI data, about Rs 2,300 a year on Rs 10 lakh invested.

What is the one-year return of Nippon India Nifty Pharma ETF?

The NAV changed by 23.6% over the last year; past returns do not indicate future returns.

Data: AMFI NAVs and expense ratios and the fund house's monthly portfolio disclosures. This page states facts and is not a recommendation to buy or sell. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not guarantee future results.